Ketamine nasal spray will be subsidized for treatment-resistant depression—what you need to know about Spravato

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making it much cheaper for the estimated 30,000 Australians with treatment-resistant depression. This is when a patient has tried multiple forms of treatment for major depression—usually at least two antidepressant medications—without any improvement.

👉 Full Story